Micro Emerging Active

ImmunityBio FDA warning letter

Score
0.3
Velocity
▲ 0.0
Articles
4
Sources
1

Summary

An article belongs to this narrative if it discusses the FDA warning letter received by ImmunityBio.

Related Articles

ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include ANKTIVA for Papillary-Only NMIBC

Yahoo Finance · Mar 25, 2026
Mixed

Why ImmunityBio Stock Is Down More Than 20% Today

Yahoo Finance · Mar 24, 2026
Bearish

Sources

Jim Cramer on ImmunityBio: “I Would Encourage You to Own … Yahoo Finance
ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy … Yahoo Finance
ImmunityBio (IBRX) Announces NCCN Update Clinical Practice Guidelines to Include … Yahoo Finance
Why ImmunityBio Stock Is Down More Than 20% Today Yahoo Finance

Timeline

Last Updated Mar 24, 2026